Results 91 to 100 of about 43,594 (266)

Belhassen Syndrome in Teenager Originating from Left Anterior Fascicle

open access: yesJournal of Cardiac Arrhythmias, 2020
A 16-year-old female patient was hospitalized due to narrow QRS tachycardia suggestive of fascicular ventricular tachycardia. Initially, the differential diagnosis with supraventricular tachycardia can be challenging.
Livia Teixeira Martins e Silva   +4 more
doaj   +4 more sources

Crystallinity‐Programmed Memristive Devices Enable Reconfigurable Neuromorphic Sensing With Hardware VMM Readout

open access: yesAdvanced Electronic Materials, Volume 11, Issue 21, December 17, 2025.
Memristive device exhibits multi‐modal switching between volatile and nonvolatile states using a simple measurement setup. In‐sensor reservoir computing based on memristive device accurately reconstructs ECG waveforms and predicts pH changes at ultralow energy.
June Soo Kim   +7 more
wiley   +1 more source

Alcohol and arrhythmias: a comprehensive review. [PDF]

open access: yes, 2010
The use of alcohol as a social lubricant has been ubiquitous in human societies since ancient times. It has also long been recognized that alcohol produces undesirable cardiovascular effects, especially when imbibed in excess. Numerous investigators have
Figueredo, M.D., Vincent M, George, Anil
core   +2 more sources

Adverse drug reactions, particularly liver disorders, drive interruptions in anti‐tuberculosis treatment: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 12, Page 3461-3470, December 2025.
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon   +10 more
wiley   +1 more source

Adenosine-induced non-sustained polymorphic ventricular tachycardia [PDF]

open access: yes, 2017
Adenosine has become widely used because of its diagnostic and therapeutic value in the emergency management of arrhythimias. it produces transient heart block by slowing conduction through tile AV node and thus terminates supraventricular tachycardias ...
CANDINAS, R., ROMER, M.
core  

Cardiovascular Safety Landscape of ADT in Prostate Cancer Treatment Based on Real‐World Analysis

open access: yesCancer Medicine, Volume 14, Issue 24, December 2025.
ABSTRACT Background Prostate cancer is among the most prevalent malignancies worldwide, and cardiovascular disease (CVD) is a major non‐cancer cause of death in affected patients. Androgen deprivation therapy (ADT), a mainstay treatment, has raised concerns about cardiotoxicity, yet the CVD risks of individual ADT agents remain unclear.
Wei Wang   +7 more
wiley   +1 more source

Dermatomyositis and supraventricular tachycardia

open access: yesInternational Archives of Medicine, 2008
Dermatomyositis is an idiopathic inflammatory myopathy, often associated with an underlying malignancy. Its prevalence rate is approximately one per 100,000 in the general population, and is even rarer without evidence of a cancer. Dermatomyositis rarely involves myocardial muscle fibers, but has shown to be associated with cardiac arrhythmias.We ...
Dhoble, Abhijeet   +2 more
openaire   +2 more sources

A Rare Case of Left Ventricular Noncompaction Discovered During Severe Rhythm Disorder: About a Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT The discovery of non‐compaction cardiomyopathy of the left ventricle (NCVG), although rare, is not exceptional. This case involved a 36‐year‐old man admitted with palpitations, exertional dyspnea, hypersudation, and anxiety. The electrocardiogram revealed ventricular tachycardia.
Martin Wendlassida Nacanabo   +6 more
wiley   +1 more source

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]

open access: yesActa Medica Iranica, 1986
Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY    +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy